15.3 - Detailed Study Notes on G Protein–Coupled Receptors
15.3 Structure and Mechanism of G Protein–Coupled Receptors
Introduction to G Protein–Coupled Receptors (GPCRs)
Definition: GPCRs are a significant class of receptors characterized by their ability to couple with G proteins, playing a key role in mediating various cellular responses to external stimuli.
Number in Human Genome: Approximately 800 functional GPCRs are encoded by the human genome, representing about 4% of known human proteins.
Signal Detection: GPCRs detect and respond to a wide range of signals, including:
Odorants (smell)
Tastants (taste)
Neurotransmitters
Hormones involved in metabolic processes
Growth factors
Physical stimuli (e.g., photons of light)
Medical Importance: Around 35% of all drugs on the market act on GPCRs (as agonists or antagonists).
Drug Targets: 134 GPCRs are known drug targets in the USA and EU.
Pharmaceutical Importance of GPCRs
Table 15-1: Examples of GPCRs and their associated drugs:
Receptor
Natural Ligand
Location
Physiological Function
Drug
Medical Use
Histamine H2
Histamine
Acid-secreting cells in stomach
Stimulates acid secretion
Cimetidine (Tagamet), Ranitidine (Zantac)
Reduces stomach acidity; treats peptic ulcers
Histamine H1
Histamine
Smooth muscle, vascular cells
Increases vascular permeability
Fexofenadine (Allegra), Loratadine (Claritin)
Alleviates allergy symptoms
Serotonin
Serotonin
CNS
Synaptic transmission between neurons
Clozapine, Risperidone (antagonists)
Treats schizophrenia
Angiotensin II
Angiotensin II
Vascular smooth muscles
Constricts blood vessels; increases BP
Losartan (Cozarr) (antagonist)
Reduces hypertension
Epinephrine
Epinephrine
Smooth muscle lining the airway
Facilitates respiration
Salmeterol (Severent) (agonist)
Treats asthma; chronic obstructive pulmonary disease
Leukotrienes
Leukotrienes
Bronchial tubes and lungs
Contracts smooth muscles
Montelukast (Singulair) (antagonist)
Treats asthma; seasonal allergies
Common Elements of GPCR Signal Transduction
All GPCR signal transduction pathways contain:
Membrane-embedded receptor with seven membrane-spanning alpha helices.
Heterotrimeric G protein acting as a receptor-activated switch (active GTP-bound and inactive GDP-bound states).
Membrane-bound effector protein.
Amplification and desensitization proteins, including protein kinases and second messengers such as cAMP.
Effect Duration: GPCR-mediated pathways generally result in short-term cellular effects by modifying existing proteins, such as enzymes and ion channels.
Basic Structure of All GPCRs
Common Structure:
Seven transmembrane alpha-helices (H1 to H7)
Four extracellular segments (E1 to E4)
Four cytosolic segments (C1 to C4)
Orientation:
N-terminus is located on the exoplasmic side of the membrane.
C-terminus is on the cytosolic side.
GPCRs are anchored in the plasma membrane by hydrophobic amino acids present in the alpha-helices.
Families of GPCRs
Diversity: GPCRs are categorized into various families based on their sequence and structure.
Family A: Largest family; examples include β-adrenergic receptors.
Ligand Binding Example: Epinephrine binds to β-adrenergic receptors via 15 amino acid residues and forms non-covalent bonds with specific side chains (serines and asparagines).
Family B: Includes receptors like the glucagon receptor with a large exoplasmic domain.
Family C: Contains excitatory neurotransmitter receptors like the glutamate receptor with a unique venus flytrap domain for ligand binding.
Activation Mechanism of GPCRs
Ligand binding induces a conformational change in the GPCR enabling it to interact with G proteins.
G Protein Activation: The G protein consists of three subunits: α, β, and γ.
GDP bound to α is released upon receptor activation, and GTP binds, activating the α subunit.
Dissociation: The active α subunit dissociates from β and γ, leading to downstream signaling effects.
Signal Amplification and Duration
Relaxation processes for GPCR activation include:
GTP Hydrolysis: The intrinsic GTPase activity of the α subunit hydrolyzes GTP to GDP, deactivating the signaling.
Feedback Mechanisms: GTPase-activating proteins (GAPs) and regulators of G protein signaling (RGS) can further enhance GTP hydrolysis, refining the signaling duration.
Experimental Evidence and Observations
FRET: Used to observe the activation of G proteins in live cells, confirming rapid dissociation of G protein complexes upon ligand binding.
Experimental Methods: Development of fluorescent proteins allows visualization of protein interactions and signal transduction in real-time.
Toxins and GPCR Function
Certain bacterial toxins, such as those produced by Vibrio cholerae, modify G proteins preventing GTP hydrolysis, leading to prolonged activation and severe physiological consequences like watery diarrhea.
Distinct G Proteins and Their Effectors
There are multiple types of G proteins that GPCRs can activate, with distinct second messenger pathways:
Adenylyl Cyclase Activation: Leads to cAMP production;
Phospholipase C Activation: Increases in inositol trisphosphate (IP3) and diacylglycerol (DAG).
Regulatory Diversity: Humans possess 21 distinct α subunits from 16 genes that diversify GPCR signaling responses.
Key Concepts Summary
Structure: GPCRs have a unique arrangement of seven membrane-spanning α helices and bind ligands leading to conformational changes activating associated G proteins.
Functionality: GPCRs couple with heterotrimeric G proteins, with ligand binding altering receptor conformation to activate downstream signaling processes.
Specificity and Duration: Distinctions in α subunits define specific cellular responses, with mechanisms in place to regulate and terminate signaling efficiently.
Physiological Relevance: Research also highlights their role in critical biological functions like appetite regulation and the impact of various ligands on human health.